UNIGE document Scientific Article - Review
previous document  unige:19686  next document
add to browser collection

Treatment strategies for acute pulmonary embolism

Published in Expert Opinion on Pharmacotherapy. 2009, vol. 10, no. 7, p. 1159-1171
Abstract BACKGROUND: Acute pulmonary embolism (PE) is a life-threatening condition that has been treated with anticoagulation for almost 50 years. OBJECTIVES: To review the current treatment options for PE and discuss recently published new features. METHODS: We reviewed literature involving the treatment strategies for venous thromboembolism (VTE) and in particular pulmonary embolism. Specific attention was drawn towards the evidence of the present treatment and of drugs being studied in Phase III trials. RESULTS/CONCLUSIONS: Treatment of acute PE consists of parenteral administration of heparin, low-molecular-weight heparin or fondaparinux overlapped and followed by oral vitamin K antagonists for a minimum of 3 months. Contemporary features include the emergence of new anticoagulant drugs such as oral synthetic inhibitors of thrombin or factor Xa. The duration of anticoagulation for unprovoked VTE remains highly debated.
Keywords Acute DiseaseEmbolectomyFemaleHumansPregnancyPregnancy Complications, Cardiovascular/drug therapy/surgery/therapyPulmonary Embolism/complications/drug therapy/surgery/*therapyThrombolytic TherapyVena Cava Filters
PMID: 19405790
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Research groups Geneva Platelet Group (13)
La maladie thromboembolique veineuse (808)
(ISO format)
BLONDON, Marc, BOUNAMEAUX, Henri, RIGHINI, Marc Philip. Treatment strategies for acute pulmonary embolism. In: Expert Opinion on Pharmacotherapy, 2009, vol. 10, n° 7, p. 1159-1171. doi: 10.1517/14656560902911470 https://archive-ouverte.unige.ch/unige:19686

364 hits

0 download


Deposited on : 2012-04-23

Export document
Format :
Citation style :